期刊文献+

新型纳米靶向给药系统载体材料的设计 被引量:10

Design of Novel Nanocarrier Materials for Targeted Drug Delivery System
原文传递
导出
摘要 新型纳米靶向给药系统的研究与开发对于难治愈性疾病(尤其是肿瘤)的治疗具有重大意义,而其发展很大程度上取决于载体材料的设计。构思巧妙、设计合理的载体材料能使载体实现靶向功能,将药物定位浓集于病灶部位,并最大限度地发挥高效低毒的作用。基于不同的靶向策略,包括被动靶向、主动靶向和响应肿瘤微环境的靶向,综述了近年来一些新型纳米载体材料的设计,为新型纳米靶向给药系统的研究提供参考。 The novel targeted drug delivery system plays an important role in the treatment of refractory and incurable diseases (especially cancer). Its development to a great extent depends on the design of nanoearrier materials. Nanocarrier materials with intricate and rational design are beneficial to targeting drug to disease site, producing maximum efficacy and minimal side effects. In this review, the design of nnvel nanocarrier materials was reviewed from the perspective of targeting strategies, including passive targeting, active targeting and tnmor microenvironment stimuli-responsive targeting, so as to provide theoretical references for the development of novel targeted drug delivery systems.
作者 鞠曹云 张灿
出处 《药学进展》 CAS 2016年第4期250-260,共11页 Progress in Pharmaceutical Sciences
基金 国家自然科学基金(No.81273468 No.81473153 No.81503003)
关键词 靶向给药系统 纳米载体 被动靶向 主动靶向 肿瘤微环境响应 targeted drug delivery system: nanocarrier passive targeting active targeting tumor microenvironment stimuli-response
  • 相关文献

参考文献62

  • 1Knop K, Hoogenboom R, Fischer D, et al. Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives [J]. Angew Chem lnt EdEngl, 2010, 49(36): 6288-6308.
  • 2Yoo J W, Chambers E, Mitragotri S. Factors that control the circulation time of nanoparticles in blood: challenges, solutions and future prospects [J]. CurrPharm Des', 2010, 16(21): 2298-2307.
  • 3Yang Q, Lai S K. Anti-PEG immunity: emergence, characteristics and unaddressed questions [J]. Wiley lnterdiscip Rev Nanomed Nanobiotechnol, 2015, 7(5): 655-677.
  • 4Li Y, Liu R, Shi Y, et al. Zwitterionic poly(carboxybetaine)-based cationic liposomes for effective delivery of small interfering RNA therapeutics without accelerated blood clearance phenomenon [J] Theranostics, 2015, 5(6): 583-596.
  • 5Li Y, Liu R, Yang J, et al. Enhanced retention and anti-tumor efficacy of liposomes by changing their cellular uptake and pharmacokinetics behavior [J]. Biomaterials, 2015, 41: 1-14.
  • 6Kierstead P H, Okochi H, Venditto V J, et al. The effect of polymer backbone chemistry on the induction of the accelerated blood clearance in polymer modified liposomes [J]. J Controlled Release, 2015, 213:1-9.
  • 7Yao X, Xie C, Chen W, et al. Platinum-incorporating poly(N- vinylpyrrolidone)-poly(aspartic acid) pseudoblock copolymer nanopartictes for drug delivery [J]. Biomacromolecules, 2015, 16(7): 2059-2071.
  • 8Keller S, Wilson J T, Patilea G I, et al. Neutral polymer micelle carriers with pH-responsive, endosome-releasing activity modulate antigen trafficking to enhance CD8~ T cell responses [J]. J Controlled Release, 2014, 191: 24-33.
  • 9Smith C E, Ernenwein D, Shkumatov A, et al. Hydrophilic packaging of iron oxide nanoclusters for highly sensitive imaging [J]. Biomaterials, 2015, 69: 184-190.
  • 10Yang H M, Park C W, Ahn T, et al. A direct surface modification of iron oxide nanoparticles with various poly(amino acid)s for use as magnetic resonance probes [J]. J Colloid Interface Sci, 2013, 391 : 158-167.

同被引文献142

引证文献10

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部